MORRISTOWN-HAMBLEN HOSPITAL — History
CCN 440030 | 3-year financial timeline | COVID resilience: 56/100
🛡️ Public data only — no PHI permitted on this instance.
$127M
Latest Revenue (FY2022)
+5.4%
Revenue CAGR (3yr)
11.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $114M | $121M | $127M | +4.9% | +5.4% |
| Operating Expenses | $100M | $110M | $112M | +1.2% | +5.6% |
| Operating Margin | 12.2% | 8.7% | 11.8% | +36.6% | -1.5% |
| Net Income | $14M | $10M | $15M | +43.2% | +3.8% |
| Licensed Beds | 102 | 102 | 102 | +0.0% | +0.0% |
| Total Patient Days | 30,296 | 31,323 | 30,463 | -2.7% | +0.3% |
| Medicare Day % | 26% | 21% | 20% | -3.6% | -12.1% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 56/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +11.1% ($114M → $127M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+5.4%
This Hospital
+7.6%
State Avg
Latest Margin
11.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $133M | 11.6% |
| FY2024 (proj) | $139M | 11.5% |
| FY2025 (proj) | $146M | 11.3% |